Results 121 to 130 of about 192,514 (206)

Evaluation of the Effects of COVID-19 Infection and COVID-19 mRNA Vaccine on Ovarian Reserve. [PDF]

J Clin Med
Basibuyuk Z, Cebi Basibuyuk C, Okumus S, Oncul M, Ocal KP.   +4 more
europepmc   +1 more source

A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial. [PDF]

Nat Med
Ploquin A, Mason RD, Holman LA, Happe M, Widge AT, Novik L, Ortega-Villa AM, Yamshchikov GV, Gordon IJ, Ola A, Arthur A, Costner PJM, Mendoza F, Saunders J, Wang X, Whalen WR, Utoh J, Cunningham J, Loftus LN, Heimann A, Korzeniwsky K, Andrew SF, Lamb E, Shyam Sunder S, Thompson A, McDonald M, Foulds KE, Sullivan NJ, Bahorich J, Coates EE, Loomis RJ, Graham BS, Bok K, Himansu S, Leav B, Dempsey W, Beigel JH, Roederer M, Dropulic LK, VRC 322 study team.   +39 more
europepmc   +1 more source

Integrative bioinformatics approach to the mRNA vaccine development for the human papillomavirus using the capsid protein. [PDF]

Biol Direct
He S, Zubair A, Ahmad F, Shahani MY, Zeng L, Afghan N.   +5 more
europepmc   +1 more source

One-component ionizable amphiphilic Janus dendrimers as a delivery platform for efficient mRNA vaccine development. [PDF]

Sci Adv
Ona NA, Zhang D, Lindesmith LC, Park WJ, Meshanni JA, Berkihiser S, Vasserman JA, Toshtzar S, Moore NC, Williams B, Nakagawa B, Baboo I, Pan L, Cheng W, Mercado-López X, Bonilla-Acosta W, Brewer-Jensen PD, Zweigart MR, Reyes YI, Mallory ML, May SR, Zhou Y, Percec V, Baric RS, Li Y, Weissman D, Atochina-Vasserman EN.   +26 more
europepmc   +1 more source

Foot-and-mouth disease virus-like particle mRNA vaccine induces strong humoral and cellular immunity. [PDF]

Appl Microbiol Biotechnol
Liu H, Zhang Y, Mu S, Hou F, Jiang L, Wang Z, Dong H, Mehdi MM, Guo H, Sun S.   +9 more
europepmc   +1 more source

In silico design of a novel multi-epitope mRNA vaccine candidate for BtHKU5-CoV-2 using immunoinformatics. [PDF]

PLoS Negl Trop Dis
Zheng N, Xu Y.
europepmc   +1 more source

The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients. [PDF]

Clin Transl Immunology
Hellgren F, Arcoverde Cerveira R, Lindgren G, Chen P, Lenart K, Ols S, Cagigi A, Valentini D, Barranco MR, Vitus ES, Corcoran M, Gwon YD, Forsell MN, Evander M, COVAXID Study Group, Bergman P, Buggert M, Ljunggren HG, Aleman S, Karlsson Hedestam GB, Björklund A, Nordlander A, Ljungman P, Mielke S, Loré K.   +24 more
europepmc   +1 more source

Global landscape of mRNA vaccine clinical trials: a systematic analysis of ClinicalTrials.gov data. [PDF]

Front Public Health
Liu S, Zhou T, Wang M, Xiang W, Wu J.
europepmc   +1 more source

Recent Progress in Sequence Optimization of mRNA Vaccine: Biological Mechanism, Quantitative Metrics, and Computational Model. [PDF]

Bioinform Biol Insights
Wang Y, Cai Y, Wu Z, Zhang J, Turtle L, Meng J.   +5 more
europepmc   +1 more source

Development of an mRNA Vaccine for Tick-Borne Encephalitis: Selection of a Prototype Virus Strain. [PDF]

Vaccines (Basel)
Nikiforova MA, Gushchin VA, Kleymenov DA, Kocherzhenko AM, Bykonia EN, Mazunina EP, Kozlova SR, Russu LI, Kuznetsova NA, Shidlovskaya EV, Marchuk EV, Usachev EV, Usacheva OV, Shcheblyakov DV, Kozlova IV, Tkachev SE, Pochtovyi AA, Zlobin VI, Logunov DY, Gintsburg AL.   +19 more
europepmc   +1 more source